Apoptosis in lung fibrosis and repair

Chest

Volumn 122, Issue 6 SUPPL., 2002, Pages 293S-298S

  Uhal, Bruce D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Fibrosis; Lung; Pulmonary pathogenesis

Indexed keywords

APOPTOSIS; CELL TYPE; CONFERENCE PAPER; FIBROGENESIS; HUMAN; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG PARENCHYMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE REPAIR;

EID: 0036933503     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.6_suppl.293S     Document Type: Conference Paper

References (52)

1. Bursch W, Patte S, Putz B, et al. Determination of the length of the histological stages of apoptosis in normal liver and altered hepatic fool of rats. Carcinogenesis 1990; 11:847-853
2. Uhal BD. Cell cycle kinetics in the alveolar epithelium. Am J Physiol 1997; 272:L1031-L1045
3. Roth JA, Nguyen D, Lawrence DD, et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 1996; 2:985-991
4. Pearson AS, Spitz FR, Swisher SG, et al. Upregulation of the proapoptotic mediators bax and bak following adenovirus-mediated p53 gene transfer in lung cancer cells. Clin Cancer Res 2000; 6:887-890
5. Wilman KG. New p53-based anti-cancer therapeutic strategies. Med Oncol 1998; 15:222-228
6. Schittney J, Djonov V, Fine A, et al. Programmed cell death contributes to postnatal lung development. Am J Respir Cell Mol Biol 1998; 18:786-793
7. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999; 160:S5-S11
8. Meagher L, Cousin JM, Seckl R, et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156:4422-4428
9. Bardales RH, Xie SS, Schaefer RF, et al. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 1997; 149:845-852
10. Polunovsky V, Chen B, Henke C, et al. Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest 1993; 92:388-397
11. Durmowicz AG, Stenmark KR. Mechanisms of structural remodeling in chronic pulmonary hypertension. Pediatr Rev 1999; 20:e91-e102
12. Segura L, Pardo A, Gaxiola M, et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117:684-694
13. Uhal BD. Fas and apoptosis in the alveolar epithelium: Holes in the dike [editorial]? Am J Physiol 2001; 281:L326-L327
14. Fehrenbach H, Kasper M, Koslowski R, et al. Alveolar epithelial type II cell apoptosis in vivo during resolution of keratinocyte growth factor-induced hyperplasia in the rat. Histochem Cell Biol 2000; 11:49-61
15. Selman M. Pulmonary fibrosis: Human and experimental disease. In: Rojkind M, ed. Connective Tissue in Health and Disease. Boca Raton, FL: CRC Press, 1990; 123-188
16. Eastman A. Apoptosis: A product of programmed and unprogrammed cell death. Toxicol Appl Pharmacol 1993; 121:160-164
17. Kuwano K, Kunitake R, Kawasaki M, et al. p21 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154:477-483
18. Uhal BD, Joshi I, Ramos C, et al. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 1998; 275:L1192-L1199
19. Uhal BD, Joshi I, True A, et al. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am J Physiol 1995; 269:L819-L828
20. Panos RJ, Rubin JS, Csaky KG, et al. Keratinocyte growth factor and hepatocyte growth factor/scatter factor ar heparin-binding growth factors for alveolar type II cells in fibroblast conditioned medium. J Clin Invest 1993; 92:969-977
21. Wang R, Ramos C, Joshi I, et al. Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am J Physiol 1999; 277:L1158-L1164
22. Wang R, Zagariya A, Ibarra-Sunga O, et al. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol 1999; 276:L885-L889
23. Katwa LC, Campbell SE, Tyagi SC, et al. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 1997; 2:I375-I386
24. Weber KT. Fibrosis, a common pathway to organ failure: Angiotensin II and tissue repair. Semin Nephrol 1997; 17:467-491
25. Barbas-Filho J, Ferreira M, Sesso A, et al. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia (UIP). J Clin Pathol 2001; 54:132-138
26. Haschek WM, Witschi HP. Pulmonary fibrosis: A possible mechanism. Toxicol Appl Pharmacol 1979; 51:75-487
27. Simon RH. Alveolar epithelial cells in pulmonary fibrosis. In: Phan SH, Thrall RS, eds. Pulmonary fibrosis (vol 80). 1995; New York, NY: Dekker; 511-540
28. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134:136-151
29. Witschi H. Responses of the lung to toxic injury. Environ Health Perspect 1990; 85:5-13
30. Adamson IYR, Bowden DH. Pulmonary injury and repair: Organ culture studies of murine lung after oxygen. Arch Pathol Lab Med 1976; 100:640-643
31. Hagimoto N, Kuwano K, Miyazaki H, et al. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of FAS antigen. Am J Respir Cell Mol Biol 1997; 17:272-278
32. Hagimoto N, Kuwano K, Nomoto Y, et al. Apoptosis and expression of FAS/FAS ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 1997; 16:91-101
33. Kuwano K, Hagimoto N, Kawasaki M, et al. Essential roles of the Fas/Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 1999; 104:13-19
34. Wang R, Ibarra-Sunga O, Pick R, et al. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol 2000; 279:L143-L151
35. Uhal BD, Gidea C, Bargout R, et al. Captopril inhibits apoptosis in human lung epithelial cells: A potential antifibrotic mechanism. Am J Physiol 1998; 275:L1013-L1017
36. Kuwano K, Kunitake R, Maeyama T, et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol 2001; 280:L316-L325
37. Molteni A, Ward W, Ts'ao C, et al. Monocrotaline-induced pulmonary fibrosis in rats: Amelioration by captopril and penicillamine. Proc Soc Exp Biol Med 1985; 180:112-120
38. Ward W, Molteni A, Ts'ao C, et al. The effect of captopril on benign and malignant reactions in irradiated rat skin. Br J Radiol 1990; 63:349-354
39. Wang R, Zagariya A, Ang E, et al. Fas-induced apoptosis of alveolar epithelial cells requires angiotensin II generation and receptor interaction. Am J Physiol 1999; 277:L1245-L1250
40. Wang R, Alam G, Zagariya A, et al. Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo. J Cell Physiol 2000; 185:253-259
41. Mallampalli RM, Peterson E, Carter A, et al. TNF-α increases ceramide without inducing apoptosis in alveolar type II epithelial cells. Am J Physiol 1999; 276:L481-L490
42. Brown LA, Harris F, Guidot D. Chronic ethanol ingestion potentiates TNF-α-mediated oxidative stress and apoptosis in rat type II cells. Am J Physiol 2001; 281:L377-L386
43. Filippatos G, Lalude O, Ramaswaran N, et al. Regulation of apoptosis by vasoactive peptides. Am J Physiol 2001:L749-L761
44. Bargout R, Jankov A, Dincer E, et al. Amiodarone induces apoptosis in human and rat alveolar epithelial cells in vitro. Am J Physiol 2000; 278:L1039-L1044
45. Dincer H, Gangopadhyay N, Wang R, et al. Norepinephrine induces alveolar epithelial apoptosis mediated by α, β and angiotensin receptor activation. Am J Physiol Lung Cell Mol Physiol 2001; 281:L624-L630
46. Brasier A, Junyi L, Copland A. Transcription factors modulating angiotensinogen gene expression in hepatocytes. Kidney Int 1994; 46:1564-1566
47. Leri A, Claudia PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system, and decreases the Bc1-2-to-Bax protein ratio in the cell. J Clin Invest 1998; 101:1326-1342
48. Kupfahl C, Pink D, Friedrich K, et al. Angiotensin II directly increases transforming growth factor β1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc Res 2000; 46:463-475
49. Klahr S, Morrissey J. Angiotensin II and gene expression in the kidney. Am J Kidney Dis 1998; 31:171-176
50. Wang Q, Wang W, Hyde D, et al. Reduction of bleomycin-induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax 1999; 54:805-812
51. Gauldie J, Sime P, Xing Z, et al. Transforming growth factor beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis. Curr Top Pathol 1999; 93:35-45
52. Antoniades HN, Bravo M, Avila RE, et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990; 86:1055-1064